Hi-Tech Pharmacal gets OK for generic ulcer drug
Hi-Tech Pharmacal chief executive David Seltzer visits the sterile packaging area in the Amityville plant. (June 3, 2003) Credit: Pablo Garcia Corradi, 2003
Amityville-based Hi-Tech Pharmacal Co. Inc. has gotten federal approval to sell a generic version of Zantac syrup, a treatment for duodenal ulcers.
The U.S. Food and Drug Administration granted final approval for ranitidine syrup, the generic for GlaxoSmithKline’s Zantac.
The potential annual market for ranitidine syrup, a treatment for heartburn or acid reflux, is about $21 million, the company said.
Ranitidine is a histamine-2 receptor antagonist (a group often called H2 blockers) that is prescribed to reduce stomach acid. These include cimetidine (Tagamet), famotidine (Pepcid), nizatidine (Axid) and ranitidine (Zantac).
A report in December indicated that popular acid-reduction drugs, including proton pump inhibitors and histamine-2 receptor antagonists, may raise the risk of pneumonia.
Photo: Hi-Tech Pharmacal chief executive David Seltzer visits the sterile packaging area in the Amityville plant.
Rain, strong winds eye LI ... Not guilty plea in Gilgo Beach murder ... Woman sentenced in brothel case ... Let's Go: Holidays in Manorville
Rain, strong winds eye LI ... Not guilty plea in Gilgo Beach murder ... Woman sentenced in brothel case ... Let's Go: Holidays in Manorville
